Screener
Assembly Biosciences ASMB EPS (Diluted)
EPS (Diluted) at other companies
Other financials
Where this comes from
Reported directly by Assembly Biosciences in its filing.
Tagged under the XBRL concept us-gaap:EarningsPerShareDiluted.
The source filing: Assembly Biosciences’s 10-Q, filed May 7, 2026. Open the filing →
- Filed
- May 7, 2026, 4:17 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-211987
FAQ
- What is Assembly Biosciences's EPS (diluted)?
- Assembly Biosciences (ASMB) reported EPS (diluted) of -$0.54 in Q1 2026.
- How has Assembly Biosciences's EPS (diluted) changed year-over-year?
- Assembly Biosciences's EPS (diluted) increased by 53.8% year-over-year, from -$1.17 to -$0.54.
- What is the long-term trend for Assembly Biosciences's EPS (diluted)?
- Over 3 years (2021 to 2024), Assembly Biosciences's EPS (diluted) has grown at a 30.6% compound annual growth rate (CAGR), from -$3.02 to -$6.72.
- What does EPS (diluted) mean?
- Net income divided by the weighted-average number of shares outstanding plus all potentially dilutive securities (stock options, convertibles, warrants). The most conservative EPS measure.
Ask your AI about Assembly Biosciences's eps (diluted).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude